Gasdermine E-Dependent Mitochondrial Pyroptotic Pathway in Dermatomyositis: A Possible Mechanism of Perifascicular

Meirong Liu1, Ling Li2, Tingjun Dai3

  • 1From the Department of Neurology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.

Insights

Mitochondrial pyroptosis, a cell death pathway involving gasdermin E (GSDME), is implicated in dermatomyositis-related perifascicular atrophy. Targeting this pathway may offer a new therapeutic strategy for dermatomyositis.

Area of Science:

  • Muscle pathology
  • Immunology
  • Cellular biology

Background:

  • Perifascicular atrophy (PFA) is a key feature of dermatomyositis (DM), but its underlying mechanisms are not fully understood.
  • Mitochondrial dysfunction and apoptosis are observed in DM, with gasdermin E (GSDME) potentially mediating pyroptosis.

Purpose of the Study:

  • To investigate the role of caspase-3 and GSDME-dependent mitochondrial pyroptosis in the pathogenesis of PFA in DM.
  • To analyze the expression of key proteins in this pathway in muscle biopsies from DM patients and controls.

Main Methods:

  • Immunohistochemical analysis of muscle biopsies from DM patients and healthy controls.
  • Quantification of protein and mRNA levels for BAX, BAK, cytochrome C, caspase-9, caspase-3, GSDME, and IL-1α.

Main Results:

  • Markers of the caspase-3 and GSDME-dependent mitochondrial pyroptotic pathway were significantly upregulated in DM muscle tissue compared to controls.
  • These markers were notably expressed in muscle fibers affected by PFA, with GSDME and IL-1α localized around vacuoles and sarcolemma.
  • Both protein and mRNA levels of these pyroptosis markers were elevated in DM patients.

Conclusions:

  • Caspase-3 and GSDME-dependent mitochondrial pyroptosis are involved in the development of PFA in dermatomyositis.
  • Targeting GSDME-dependent mitochondrial pyroptosis presents a potential therapeutic avenue for treating dermatomyositis.